Diversity and bias through dopamine D2R heteroreceptor complexes

Area of Science:

• Neuropharmacology
• Molecular biology
• Biochemistry

Background:

• Dopamine D2 receptors (D2R) function as a central hub, interacting with numerous G protein-coupled receptors (GPCRs).
• These interactions, particularly in heteroreceptor complexes, significantly influence D2R signaling pathways, including Gi/o and β-arrestin signaling.
• Allosteric receptor-receptor interactions modulate D2R function and G protein coupling.

Purpose of the Study:

• To investigate the functional consequences of D2R heterocomplex formation.
• To explore how allosteric interactions within D2R heteroreceptor complexes diversify D2R signaling.
• To highlight the therapeutic potential of targeting D2R heterocomplexes for neurological and psychiatric disorders.

Main Methods:

• Analysis of GPCR heteroreceptor complexes involving D2R.
• Investigation of signaling pathways (Gi/o and β-arrestin) modulated by receptor-receptor interactions.
• Assessment of allosteric modulation of D2R function and G protein coupling.

Main Results:

• A2AR activation antagonizes A2AR-D2R interaction, inhibiting Gi/o signaling while increasing β-arrestin2 signaling.
• 5-HT2AR agonists induce biased signaling at D2R-5-HT2AR complexes, enhancing D2R recognition and Gi/o signaling.
• Allosteric interactions in D2-NTR1 complexes inhibit D2R function and alter G protein coupling.

Conclusions:

• D2R heterocomplexes exhibit remarkable diversity in signaling bias due to allosteric receptor-receptor interactions.
• Targeting these D2R heterocomplexes presents a promising strategy for developing novel therapeutics.
• Potential applications include treatments for schizophrenia, addiction, and Parkinson's disease.